Skip to main content

Urine mRNA can predict kidney transplant rejection

Levels of mRNA for perforin and granzyme B are high in urinary cells from patients with acute transplant rejection.

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

Prompt diagnosis of acute kidney transplant rejection can improve the outcome of transplantation but it is dependent on the invasive procedure of allograft biopsy. In 29 March New England Journal of Medicine, researchers from Weill Medical College of Cornell University, New York describe a non-invasive diagnostic test for rejection based on measurement of mRNA encoding cytotoxic proteins in urinary cells.

Li et al measured mRNA encoding the cytotoxic proteins perforin and granzyme B in 24 urine specimens from 22 renal-allograft recipients with a biopsy-confirmed episode of acute rejection and in 127 samples from 63 recipients without rejection. They found that levels of mRNA for perforin and granzyme B were significantly higher in the urinary cells from the patients with acute rejection (p<0.001) (N Engl J Med 2001, 344:947-954).

Perforin and granzyme B cooperate to induce the death of target transplant cells and are present in the cytoplasmic granules of cytotoxic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Considerations for Selecting Molecular Methods for Biomarker Assessment in Hematologic Malignancies

Qiagen Logo
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays